Delivery Order SPE2DR25D2014-SPE2DR26FA2A2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $5,447.46. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The work is scheduled for completion by January 6, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,202.57. This is a firm fixed-price delivery order with an ultimate completion date of January 6, 2026, with performance to be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a contract ceiling value of $1,959.36. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competitive procurement. The order is scheduled for completion by December 30, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.12 to Amerisourcebergen Drug Corp for 100 capsules of Adderall XR 20 mg on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded task order under a larger pharmaceutical supply vehicle. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.09 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (quantity: 100s) on November 7, 2025, with an ultimate completion date of November 10, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters,...
- The Defense Logistics Agency awarded a delivery order valued at $1,563.31 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100 count) on January 6, 2026, with an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,457.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,592.16. This non-competitive, firm fixed-price delivery order is scheduled for completion by October 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $1,337.16. This competitively awarded, firm fixed-price delivery order is set to be completed by December 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Adderall XR 20 mg capsules (100 count) with a contract ceiling value of $1,040.94. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025. This...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA2A2Delivery Order
On January 9, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,559.51 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100 count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 12, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competition under which it was awarded. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc., operates this comprehensive pharmaceutical supply vehicle that enables delivery of a broad range of medications, vaccines, medical devices, and healthcare commodities to support military treatment facilities and federal healthcare systems worldwide. The IDC represents a critical component of the DLA's medical supply chain operations supporting Department of Defense healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/8/26 |